Wingrove Theresa bought IMGN
January 16, 2024 · Form 4 insider transaction
Wingrove Theresa bought 58,900 shares of ImmunoGen, Inc. at $4.83 per share, a transaction worth $284.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,900
Price
$4.83
Total value
$284.5K
InsiderWingrove Theresa
RoleOfficer
CompanyImmunoGen, Inc. (IMGN)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 16, 2024
Filing dateJanuary 18, 2024
Shares owned after62,326
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.